DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Magnesium sulfateis the generic ingredient in ten branded drugs marketed by B Braun Medical Inc, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Hq Spclt Pharma, Mylan Labs Ltd, Gland Pharma Ltd, Exela Pharma, Hospira Inc, Braintree Labs, Baxter Hlthcare, Gator Pharms, and Novel Labs Inc, and is included in twenty-three NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.
There are one hundred and forty-six drug master file entries for magnesium sulfate. Fourteen suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for magnesium sulfate
|Drug Master File Entries:||146|
|Suppliers / Packagers:||14|
|Bulk Api Vendors:||110|
|Formulation / Manufacturing:||see details|
|What excipients (inactive ingredients) are in magnesium sulfate?||magnesium sulfate excipients list|
|DailyMed Link:||magnesium sulfate at DailyMed|
Recent Clinical Trials for magnesium sulfate
Identify potential brand extensions & 505(b)(2) entrants
|University of Louisville||N/A|
|Fayoum University||Phase 4|
|Eric Albrecht||Phase 4|
Generic filers with tentative approvals for MAGNESIUM SULFATE
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.